Press release
HER2-Negative Breast Cancer Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers
HER2-Negative Breast Cancer
The increasing incidence of breast cancer is expected to drive the growth of the HER2-negative breast cancer market in the coming years. Breast cancer is characterized by the uncontrolled growth of abnormal cells in the breast, often originating in the ducts or lobules. Contributing factors to the rising incidence of breast cancer include greater awareness and enhanced screening methods, which lead to earlier and more frequent detection. HER2-negative breast cancer plays a significant role in advancing research into breast cancer by providing insights into tumor biology and treatment strategies, thereby aiding the development of more targeted therapies. For example, the Centers for Disease Control and Prevention reported in June 2024 that in 2021, 272,454 new cases of breast cancer were diagnosed in U.S. females, and in 2022, 42,211 females died from the disease. Consequently, the growing incidence of breast cancer is driving the growth of the HER2-negative breast cancer market.
Get Your HER2-Negative Breast Cancer Market Report Here:
https://www.thebusinessresearchcompany.com/report/her2-negative-breast-cancer-global-market-report
What growth opportunities are expected to drive the her2-negative breast cancer market's CAGR through 2034?
The HER2-negative breast cancer market has grown strongly, rising from $16.29 billion in 2024 to $17.62 billion in 2025 at a CAGR of 8.1%. Key growth drivers include the increasing prevalence of breast cancer, heightened awareness, rising healthcare spending, an aging population, and improved healthcare infrastructure.
The HER2-negative breast cancer market size is expected to witness substantial growth in the coming years, reaching $23.86 billion by 2029 at a CAGR of 7.9%. The market expansion is driven by increased alcohol consumption, a growing trend of unhealthy lifestyles, rising obesity rates, a surge in tobacco usage, and an increasing demand for effective treatment solutions. Key trends anticipated include advancements in diagnostic technologies, integration of targeted therapies, growing adoption of immunotherapies, FDA approvals, and continuous technological advancements.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21203&type=smp
What are the emerging trends shaping the future of the her2-negative breast cancer market?
In the HER2-negative breast cancer market, companies are focusing on securing regulatory approvals to expand their product portfolios and enhance their market presence. Regulatory approvals are granted by agencies like the FDA once a drug meets safety, efficacy, and quality standards. In October 2024, Genentech Inc., a US-based biotechnology corporation, received FDA approval for Itovebi (inavolisib), a targeted treatment for advanced hormone receptor-positive (HR+), HER2-negative breast cancer with a PIK3CA mutation. This approval allows Itovebi to be used in combination with palbociclib and fulvestrant, improving progression-free survival for patients compared to standard treatments.
Which growth-oriented segments of the her2-negative breast cancer market are leading the industry's development?
The HER2-negative breast cancer market covered in this report is segmented -
1) By Treatment Type: Chemotherapy, Hormone Therapy, Targeted Therapy, Immunotherapy
2) By Cancer Stage: Early Stage, Locally Advanced Stage, Metastatic Stage
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
Subsegments:
1) By Chemotherapy: Anthracyclines, Taxanes, Platinum-Based Chemotherapy, Alkylating Agents, Antimetabolites
2) By Hormone Therapy: Selective Estrogen Receptor Modulators (SERMs), Aromatase Inhibitors, Selective Estrogen Receptor Degraders (SERDs)
3) By Targeted Therapy: CDK4/6 Inhibitors, PI3K Inhibitors, PARP Inhibitors
4) By Immunotherapy: Immune Checkpoint Inhibitors, Tumor-Infiltrating Lymphocyte (TIL) Therapy
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21203
What regions are leading the charge in the her2-negative breast cancer market?
North America was the largest region in the HER2-negative breast cancer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the HER2-negative breast cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the her2-negative breast cancer market?
Major companies operating in the HER2-negative breast cancer market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, Sanofi S.A., AstraZeneca PLC, Novartis International AG, Eli Lilly and Company, Amgen Inc., Daiichi Sankyo Company Limited, Jiangsu Hansoh Pharmaceutical Co. Ltd., BeiGene Ltd., Chipscreen Biosciences Ltd., F. Hoffmann-La Roche Ltd, PharmAbcine Inc., Adagene Inc., H3 Biomedicine Inc., Radius Health Inc., Zenith Epigenetics Ltd.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=21203&type=smp
What Is Covered In The HER2-Negative Breast Cancer Global Market Report?
•Market Size Forecast: Examine the her2-negative breast cancer market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the her2-negative breast cancer market for a structured understanding.
•Key Players Overview: Analyze major players in the her2-negative breast cancer market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the her2-negative breast cancer market.
•Segment Contributions: Evaluate how different segments drive overall growth in the her2-negative breast cancer market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the her2-negative breast cancer market.
•Industry Challenges: Identify potential risks and obstacles affecting the her2-negative breast cancer market.
•Competitive Landscape: Review strategic developments in the her2-negative breast cancer market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release HER2-Negative Breast Cancer Market Forecast 2025-2034: Analysing Major Trends, Opportunities, and Growth Drivers here
News-ID: 3934468 • Views: …
More Releases from The Business Research Company
Artificial Intelligence (AI)-Enhanced Point-Of-Sale (POS) Fraud Market Study Hig …
The artificial intelligence (AI)-enhanced point-of-sale (POS) fraud market is on the brink of remarkable expansion, driven by growing concerns around payment security and the rising reliance on smart fraud detection technologies. This market is rapidly evolving as businesses seek more effective ways to protect transactions and prevent financial losses in an increasingly digital payment landscape.
Projected Market Size and Growth Trajectory of the AI-Enhanced POS Fraud Market
The market for AI-enhanced…
Cash And Coin Recycling System Market Report 2026 Market Outlook Supported By A …
The cash and coin recycling system market is set to experience significant growth in the coming years, driven by technological advancements and increasing demand for efficient cash management solutions. As businesses and financial institutions seek to optimize cash handling processes, this sector is poised for robust expansion through 2030.
Projected Market Size and Growth Rate of the Cash and Coin Recycling System Market
The market for cash and coin recycling systems…
Cards & Payments Market Insights Highlight Segment Expansion And Market Leadersh …
The cards and payments sector is on track for significant expansion in the coming years, driven by technological advancements and evolving consumer preferences. This market is witnessing rapid transformation as businesses and individuals increasingly embrace digital financial solutions, reshaping how transactions are conducted globally.
Forecasted Market Size and Growth Trajectory for the Cards & Payments Market
The cards and payments market is projected to experience robust growth, reaching a valuation of…
Card Personalization Services Market Report Evaluates Growth Drivers, Challenges …
The card personalization services sector is set to experience significant expansion as digital payment technologies continue to evolve. With the increasing demand for customized and secure payment cards, this market is expected to see steady progress driven by several emerging factors. Below is an overview of the market's growth, key players, innovations, and segmentation details shaping its path ahead.
Projected Market Size and Growth Trajectory of Card Personalization Services
The card…
More Releases for Breast
Breast Health Monitoring App Market to Witness a Pronounce Growth during 2024-20 …
The latest market intelligence report published by WMR with the title "Global Breast Health Monitoring App Market 2024, Growth Opportunities, and Forecast" provides actionable insights on Healthcare and Pharmaceuticals industry. The report provides demand analysis, industry insights, competitive intelligence, and customer database.
The Research report on Breast Health Monitoring App Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y…
Primary Breast Cancer Survivor Phil Alderson Shines Light on Male Breast Cancer …
FOR IMMEDIATE RELEASE
Primary Breast Cancer Survivor Phil Alderson Shines Light on Male Breast Cancer During Breast Cancer Awareness Month
Liverpool, UK - October, 2023 - Phil Alderson, a primary survivor of male breast cancer, is taking bold steps this Breast Cancer Awareness Month to raise awareness of this often overlooked aspect of the disease. With a homemade cardboard sign that reads "Check Your Pecks," Phil has taken to the streets of…
Breast Health Monitoring App Market Recent Trends, In-depth Analysis, Size, and …
According to The Worldwide Market Reports, the Latest research report on "Breast Health Monitoring App Market Size, Revenue, Global Analysis, and Forecast 2023 to 2030" The Breast Health Monitoring App Market research study is a professional report with premium insights into the size of the business, current patterns, drivers, risks, potential outcomes, and major segments. The Industry Report forecasts the future growth of the market based on precise assumptions. Furthermore,…
Breast Pumps Market - Nurturing Convenience: Revolutionizing Breast Pump Technol …
Newark, New Castle, USA - new report, titled Breast Pumps Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Breast Pumps market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Breast Pumps market. The report offers an overview of the market, which…
Breast Ultrasound Market Research Report and Forecast to 2028 - Conventional Bre …
A breast ultrasound is an imaging method chiefly utilized to screen for tumours and other breast abnormalities. The ultrasound use high-frequency sound waves for the production of detailed images of the inside of the breasts.
The global Breast Ultrasound Market is expected to grow at a significant CAGR of 14.6% by 2028.
The updated report on the Breast Ultrasound market gives a precise analysis of the value chain assessment for the review…
Breast Imaging Market by Breast Ultrasound, Breast MRI, Automated Whole-Breast U …
Growth of breast imaging market driven by factors like rising incidence of breast cancer globally, growing government investments and funding for breast cancer treatment and related research, increasing awareness about early detection of breast cancer, rising geriatric population, technological advancements in breast imaging modalities, and launch of advanced breast imaging systems capable of detecting cancer in women with dense breast tissues.
Download Free PDF Brochure on Brest Imaging Market Report Now…
